Cost-effectiveness modelling in diagnostic imaging: a stepwise approach.

The efficacy of diagnostic imaging. Med Decis Making (1991) 6.86

Costs, effects and C/E-ratios alongside a clinical trial. Health Econ (1995) 6.63

Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health (2009) 4.29

A rational framework for decision making by the National Institute For Clinical Excellence (NICE). Lancet (2002) 3.26

Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol (2011) 3.14

Computerized cranial tomography. Effect on diagnostic and therapeutic plans. JAMA (1977) 2.46

Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7. Med Decis Making (2012) 2.21

A decision chart for assessing and improving the transferability of economic evaluation results between countries. Pharmacoeconomics (2004) 2.15

Challenges in systematic reviews of diagnostic technologies. Ann Intern Med (2005) 2.05

Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6. Med Decis Making (2012) 1.81

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Int J Technol Assess Health Care (2013) 1.66

Imaging of carotid arteries in symptomatic patients: cost-effectiveness of diagnostic strategies. Radiology (2004) 1.64

Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1. Med Decis Making (2012) 1.61

The uncritical use of high-tech medical imaging. N Engl J Med (2010) 1.50

The value of diagnostic information to patients with chest pain suggestive of coronary artery disease. Med Decis Making (2005) 1.44

Renal artery stenosis: cost-effectiveness of diagnosis and treatment. Radiology (2007) 1.43

Cost-effectiveness of MRI to assess for posttraumatic ligamentous cervical spine injury. Orthopedics (2014) 1.40

Cost-effectiveness analysis in the assessment of diagnostic imaging technologies. Radiology (2005) 1.39

Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Health Technol Assess (2013) 1.33

State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med Decis Making (2012) 1.24

Focusing technology assessment using medical decision theory. Med Decis Making (1988) 1.22

Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Radiology (2012) 1.15

Repeat contrast medium reactions in premedicated patients: frequency and severity. Radiology (2009) 1.14

Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2. Med Decis Making (2012) 1.12

Psychosocial impact of screening for intracranial aneurysms in relatives with familial subarachnoid hemorrhage. Stroke (2005) 0.90

18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation. Eur J Cancer (2010) 0.90

Understanding the medical and nonmedical value of diagnostic testing. Value Health (2009) 0.87

Cost-effectiveness of diagnostic imaging work-up and treatment for patients with intermittent claudication in The Netherlands. Eur J Vasc Endovasc Surg (2003) 0.86

Cost-effectiveness of magnetic resonance angiography versus intra-arterial digital subtraction angiography to follow-up patients with coiled intracranial aneurysms. Stroke (2010) 0.84

Bridging trial and decision: a checklist to frame health technology assessments for resource allocation decisions. Value Health (2011) 0.84

Cost-effectiveness analysis for imaging techniques with a focus on cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2013) 0.83

Patient preference for magnetic resonance versus conventional angiography. Assessment methods and implications for cost-effectiveness analysis: an overview. Invest Radiol (1998) 0.81

Cost-effectiveness of CTA, MRA and DSA in patients with non-traumatic subarachnoid haemorrhage. Insights Imaging (2013) 0.80

Cost-effectiveness analysis: some clarifications. Radiology (2008) 0.78

Challenges and opportunities in economic evaluations of diagnostic tests and procedures. Acad Radiol (1999) 0.77